Posted by Michael Wonder on 28 Jul 2018
Estimating drug costs: how do manufacturer net prices compare with other common US price references?
27 July 2018 - Drug costs are frequently estimated in economic analyses using wholesale acquisition cost, but what is the best approach to develop these estimates?
Pharmaceutical manufacturers recently released transparency reports disclosing net price increases after accounting for rebates and other discounts.
The objective of the study by Mattingley et al. was to determine whether manufacturer net prices could approximate the discounted prices observed by the U.S. Department of Veterans Affairs.
